STRATIFY | Brain network based stratification of mental illness

Summary
To reduce the burden of mental disorders it is a formidable aim to identify widely applicable disease markers based on
neural processes, which predict psychopathology and allow for targeted interventions. We will generate a neurobehavioural
framework for stratification of psychopathology by characterising links between network properties of brain function and
structure and reinforcement–related behaviours, which are fundamental components of some of the most prevalent mental
disorders, major depression, alcohol use disorder and ADHD. We will assess if network configurations define subtypes
within and if they correspond to comorbidity across these diagnoses. We will identify discriminative data modalities and
characterize predictors of future psychopathology.
To identify specific neurobehavioural clusters we will carry out precision phenotyping of 900 patients with major
depression, ADHD and alcohol use disorders and 300 controls, which we will investigate with innovative deep machine
learning methods derived from artifical intelligence research. Development of these methods will optimize exploitation of a
wide range of assessment modalities, including functional and structural neuroimaging, cognitive, emotional as well as
environmental measures. The neurobehavioural clusters resulting from this analysis will be validated in a longitudinal
population-based imaging genomics cohort, the IMAGEN sample of over 2000 participants spanning the period from
adolescence to adulthood and integrated with information generated from genomic and imaging-genomic meta-analyses of
>300.000 individuals.
By targeting specific neural processes the resulting stratification markers will serve as paradigmatic examples for a
diagnostic classification, which is based upon quantifiable neurobiological measures, thus enabling targetted early
intervention, identification of novel pharmaceutical targets and the establishment of neurobehaviourally informed endpoints
for clinical trials.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/695313
Start date: 01-10-2016
End date: 30-09-2023
Total budget - Public funding: 3 394 214,88 Euro - 3 394 214,00 Euro
Cordis data

Original description

To reduce the burden of mental disorders it is a formidable aim to identify widely applicable disease markers based on
neural processes, which predict psychopathology and allow for targeted interventions. We will generate a neurobehavioural
framework for stratification of psychopathology by characterising links between network properties of brain function and
structure and reinforcement–related behaviours, which are fundamental components of some of the most prevalent mental
disorders, major depression, alcohol use disorder and ADHD. We will assess if network configurations define subtypes
within and if they correspond to comorbidity across these diagnoses. We will identify discriminative data modalities and
characterize predictors of future psychopathology.
To identify specific neurobehavioural clusters we will carry out precision phenotyping of 900 patients with major
depression, ADHD and alcohol use disorders and 300 controls, which we will investigate with innovative deep machine
learning methods derived from artifical intelligence research. Development of these methods will optimize exploitation of a
wide range of assessment modalities, including functional and structural neuroimaging, cognitive, emotional as well as
environmental measures. The neurobehavioural clusters resulting from this analysis will be validated in a longitudinal
population-based imaging genomics cohort, the IMAGEN sample of over 2000 participants spanning the period from
adolescence to adulthood and integrated with information generated from genomic and imaging-genomic meta-analyses of
>300.000 individuals.
By targeting specific neural processes the resulting stratification markers will serve as paradigmatic examples for a
diagnostic classification, which is based upon quantifiable neurobiological measures, thus enabling targetted early
intervention, identification of novel pharmaceutical targets and the establishment of neurobehaviourally informed endpoints
for clinical trials.

Status

CLOSED

Call topic

ERC-ADG-2015

Update Date

27-04-2024
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Horizon 2020
H2020-EU.1. EXCELLENT SCIENCE
H2020-EU.1.1. EXCELLENT SCIENCE - European Research Council (ERC)
ERC-2015
ERC-2015-AdG
ERC-ADG-2015 ERC Advanced Grant